Briumvi 150 mg/6 mL (25 mg/mL) injection Images

Generic Name: ublituximab

This medication has been identified as Briumvi 150 mg/6 mL (25 mg/mL) injection. It is supplied by TG Therapeutics, Inc.

Briumvi is used in the treatment of Multiple Sclerosis and belongs to the drug class CD20 monoclonal antibodies. Briumvi 150 mg/6 mL (25 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Briumvi

Generic Name

ublituximab

Strength

150 mg/6 mL (25 mg/mL) injection

Availability

Prescription only

Drug Class

CD20 monoclonal antibodies

CSA Schedule

Not a controlled drug

Labeler / Supplier

TG Therapeutics, Inc.

National Drug Code (NDC)

73150-0150

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer